UK consensus from a 2025 national meeting (UKCGG, CanGene-CanVar, NHS England) on somatic and germline genetic testing pathways in haematological malignancies, covering TP53, DDX41, MPN driver genes, non-SNV variants and carrier registration with the NICPR.
Guideline
Speight et al. Somatic and germline genetic testing pathways in haematological malignancies: Best practice consensus guidelines from the 2025 national meeting organised by UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group